Women who develop heavier placentas during pregnancy have a higher risk of breast cancer, according to the results of a population-based cohort study from Sweden.
Women who develop heavier placentas during pregnancy have a higher risk of breast cancer, according to the results of a population-based cohort study from Sweden.
Researchers looked at how a number of pregnancy characteristics influenced the risk of breast cancer in a cohort of over 300,000 women. They found that compared with women whose placentas weighed less than 500 g in two consecutive pregnancies, the risk of breast cancer was almost doubled (adjusted hazard ratio, 1.82) in women whose placentas weighed between 500 and 699 g in their first pregnancy and at least 700 g in their second pregnancy (or vice versa) and was slightly more than doubled (adjusted hazard ratio, 2.05) in women whose placentas weighed at least 700 g in both pregnancies.
Other first-birth factors found to be associated with a higher risk of maternal breast cancer included delivering an infant weighing 4,500 g or more, delivering at 42 weeks or later, greater maternal age, and greater maternal height. Women with body mass indices of 29 or higher and women who smoked during pregnancy had lower rates of breast cancer than counterparts.
Cnattingius S, Torrang A, Ekbom A, et al. Pregnancy characteristics and maternal risk of breast cancer. JAMA. 2005;294:2474-2480.
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More